The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund has tied up with India's Dr. Reddy’s Laboratories to conduct the clinical trials and distribution of Sputnik V vaccine in India. Dr Reddy's tie up to manufacture Sputnik V vaccine for India.Dmitriev said if the trials succeed the vaccines will be available in India as early as November this year.The Phase I and II results have shown promise, and we will be conducting Phase-III trials in India to meet the requirements of the Indian regulators. Sputnik V vaccine could provide a credible option in our fight against COVID 19 in India,” said G V Prasad, CEO Dr Reddy's in a statement.
AstraZeneca or Oxford vaccine is also in Phase-3 trials with India’s Serum Institute contracted to produce it and has appeared ahead in the race for public use. There are two other Indian vaccines that are being developed and are in Phase I and II stage trials and have shown no significant side-effects yet.
Dr Reddy’s will perform Phase 3 clinical trials — where a vaccine is tested on thousands of human beings to establish efficacy and safety — for Sputnik V in India, as required by Indian regulatory norms.
i hope it help without sideeffects.